{"entity":{"type":"insider","cik":"0001614876","url":"/insider/0001614876","json_url":"/insider/0001614876.json","name":"Hull Hans","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2015-04-08","last":"2025-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Hull Hans","source":"filing","n_filings":10,"first_seen":"2015-04-08","last_seen":"2025-01-22"}],"transactions":[{"id":4037697,"accession":"0001746473-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-25-000004","line_url":"/filing/0001746473-25-000004#line-1","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15936.0,"shares_display":"15,936","price_per_share":11.2011,"price_display":"11.20","price_state":"stated","total_value":178500.7296,"total_display":"178,500.73","total_whole":"178,501","shares_owned_after":211558.0,"shares_owned_after_display":"211,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-22","scope":"insider"},{"id":2328185,"accession":"0001746473-24-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000127","line_url":"/filing/0001746473-24-000127#line-1","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":114444.0,"total_display":"114,444.00","total_whole":"114,444","shares_owned_after":227494.0,"shares_owned_after_display":"227,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2098812,"accession":"0001746473-24-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000004","line_url":"/filing/0001746473-24-000004#line-1","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9786.0,"shares_display":"9,786","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":168612.78,"total_display":"168,612.78","total_whole":"168,613","shares_owned_after":185069.0,"shares_owned_after_display":"185,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":7973058,"accession":"0001209191-23-044892","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-044892","line_url":"/filing/0001209191-23-044892#line-5","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20050.0,"shares_display":"20,050","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":401200.5,"total_display":"401,200.50","total_whole":"401,201","shares_owned_after":194855.0,"shares_owned_after_display":"194,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":7973052,"accession":"0001209191-23-044892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-044892","line_url":"/filing/0001209191-23-044892#line-3","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13069.0,"shares_display":"13,069","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":261380.0,"total_display":"261,380.00","total_whole":"261,380","shares_owned_after":206114.0,"shares_owned_after_display":"206,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":7973048,"accession":"0001209191-23-044892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044892","line_url":"/filing/0001209191-23-044892#line-2","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":206114.0,"shares_owned_after_display":"206,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":8221586,"accession":"0001209191-23-042829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042829","line_url":"/filing/0001209191-23-042829#line-1","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17937.0,"shares_display":"17,937","price_per_share":18.0091,"price_display":"18.01","price_state":"stated","total_value":323029.2267,"total_display":"323,029.23","total_whole":"323,029","shares_owned_after":219183.0,"shares_owned_after_display":"219,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8544608,"accession":"0001209191-23-022369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-022369","line_url":"/filing/0001209191-23-022369#line-1","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9036.0,"shares_display":"9,036","price_per_share":26.5209,"price_display":"26.52","price_state":"stated","total_value":239642.8524,"total_display":"239,642.85","total_whole":"239,643","shares_owned_after":201964.0,"shares_owned_after_display":"201,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":6667211,"accession":"0001140361-22-046567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-046567","line_url":"/filing/0001140361-22-046567#line-2","is_derivative":false,"issuer_cik":"0001614876","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001614876","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8748.0,"shares_display":"8,748","price_per_share":19.1024,"price_display":"19.10","price_state":"stated","total_value":167107.7952,"total_display":"167,107.80","total_whole":"167,108","shares_owned_after":138191.0,"shares_owned_after_display":"138,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":8932226,"accession":"0001181431-15-007961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-007961","line_url":"/filing/0001181431-15-007961#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (SVP, Business Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":37.6416,"price_display":"37.64","price_state":"stated","total_value":75283.2,"total_display":"75,283.20","total_whole":"75,283","shares_owned_after":11320.0,"shares_owned_after_display":"11,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-04","filed_date":"2015-06-05","scope":"insider"},{"id":8489683,"accession":"0001209191-15-039415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-039415","line_url":"/filing/0001209191-15-039415#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (SVP, Business Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.8698,"price_display":"30.87","price_state":"stated","total_value":154349.0,"total_display":"154,349.00","total_whole":"154,349","shares_owned_after":11320.0,"shares_owned_after_display":"11,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-04","filed_date":"2015-05-06","scope":"insider"},{"id":8148817,"accession":"0001140361-15-014738","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-014738","line_url":"/filing/0001140361-15-014738","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614876","owner_name":"Hull Hans","owner_display_name":"Hull Hans","owner_url":"/insider/0001614876","role":"Officer (SVP, Business Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Business Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":38.60265317454545,"price_display":"38.60","price_state":"stated","total_value":1061572.9623,"total_display":"1,061,572.96","total_whole":"1,061,573","shares_owned_after":4207.0,"shares_owned_after_display":"4,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001746473","name":"PLIANT THERAPEUTICS, INC.","url":"/issuer/0001746473","role":"Officer (Chief Business Officer)","n_filings":7,"first_seen":"2022-12-21","last_seen":"2025-01-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Officer (SVP, Business Operations)","n_filings":3,"first_seen":"2015-04-08","last_seen":"2015-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614876","retrieved_at":"2026-08-27T04:05:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}